SCHEMBL8769014

SCHEMBL8769014

CO[C@@]1(C)C=CC2C3CC=C4CC5(CCC4C3[C@@H](c3ccc(-c4ccc(C#N)cc4)cc3)C[C@@]21C)OCCO5

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8768855 0.89 — —
SCHEMBL8767904 0.86 — —
SCHEMBL9172917 0.85 — —
SCHEMBL8427011 0.78 PGR (0.47) —
SCHEMBL8768235 0.78 PGR (0.33) —
SCHEMBL8768992 0.78 PGR (0.32) —
SCHEMBL8767932 0.77 — —
SCHEMBL8767744 0.77 PGR (0.32) —
SCHEMBL9173750 0.76 NR3C1 (0.35) —
SCHEMBL8768832 0.76 NR3C1 (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567469-B1 14beta-H-, 14- AND 15-EN-11beta-ARYL-4-ESTRENES SCHERING AG (DE) 1997-08-27 — — EP disclosed
US-5426102-A Antigestagenic, antiandrogenic, antiglucocorticoid, antimineralcorticoid properties SCHERING AKTIENGESELLSCHAFT (DE) 1995-06-20 — — US disclosed
Send feedback